share_log

Avenue Therapeutics | EFFECT: Others

SEC announcement ·  Feb 2 19:05
Summary by Futu AI
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.